Orloff MS - Search Results

1

Eng C, Leone G, Orloff MS, Ostrowski MC. Eng C, et al. Among authors: orloff ms. Cancer Res. 2009 Sep 1;69(17):6759-64. doi: 10.1158/0008-5472.CAN-09-0985. Epub 2009 Aug 25. Cancer Res. 2009. PMID: 19706759

2

Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes.

Ashida S, Orloff MS, Bebek G, Zhang L, Zheng P, Peehl DM, Eng C. Ashida S, et al. Among authors: orloff ms. Clin Cancer Res. 2012 Mar 15;18(6):1578-87. doi: 10.1158/1078-0432.CCR-11-2535. Epub 2012 Jan 24. Clin Cancer Res. 2012. PMID: 22275508

3

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling.

He X, Wang Y, Zhu J, Orloff M, Eng C. He X, et al. Cancer Lett. 2011 Feb 28;301(2):168-76. doi: 10.1016/j.canlet.2010.11.012. Epub 2010 Dec 17. Cancer Lett. 2011. PMID: 21168265

4

Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma.

Bebek G, Orloff M, Eng C. Bebek G, et al. J Clin Bioinforma. 2011 Aug 2;1(1):21. doi: 10.1186/2043-9113-1-21. J Clin Bioinforma. 2011. PMID: 21884569 Free PMC article.

5

Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.

Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GT, Stark GR, Eng C. Tan MH, et al. Among authors: orloff ms. Breast Cancer Res Treat. 2012 Feb;131(3):849-58. doi: 10.1007/s10549-011-1500-8. Epub 2011 Apr 9. Breast Cancer Res Treat. 2012. PMID: 21479552 Free PMC article.

6

Lifetime cancer risks in individuals with germline PTEN mutations.

Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Tan MH, et al. Among authors: orloff ms. Clin Cancer Res. 2012 Jan 15;18(2):400-7. doi: 10.1158/1078-0432.CCR-11-2283. Clin Cancer Res. 2012. PMID: 22252256 Free PMC article.

7

Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort.

Orloff MS, Zhang L, Bebek G, Eng C. Orloff MS, et al. PLoS One. 2012;7(2):e31975. doi: 10.1371/journal.pone.0031975. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384118 Free PMC article.

8

Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.

Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C. Hansel DE, et al. Am J Pathol. 2010 Jun;176(6):3062-72. doi: 10.2353/ajpath.2010.090872. Epub 2010 Apr 15. Am J Pathol. 2010. PMID: 20395440 Free PMC article.

9

Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.

Orloff MS, Eng C. Orloff MS, et al. Oncogene. 2008 Sep 18;27(41):5387-97. doi: 10.1038/onc.2008.237. Oncogene. 2008. PMID: 18794875 Review.

10

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.

Wang Y, Romigh T, He X, Tan MH, Orloff MS, Silverman RH, Heston WD, Eng C. Wang Y, et al. Among authors: orloff ms. Oncogene. 2011 Oct 20;30(42):4327-38. doi: 10.1038/onc.2011.144. Epub 2011 May 2. Oncogene. 2011. PMID: 21532617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters